Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Glaxo Wellcome UK Limited Trading as GlaxoSmithKline UK, 980 Great West Road, Brentford, Middlesex, TW8 9GS
Imigran Injection.
Imigran Subject.
Pharmaceutical Form |
---|
Pre-filled syringes for use in conjunction with an auto injector for subcutaneous injection. |
Each pre-filled syringe contains 6 mg of sumatriptan base, as the succinate salt, in an isotonic solution of 0.5 ml.
For a full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Sumatriptan |
Sumatriptan has been demonstrated to be a specific and selective 5-Hydroxytryptamine1 (5HT1D) receptor agonist with no effect on other 5HT receptor (5-HT2 - 5-HT7) subtypes. The vascular 5-HT1D receptor is found predominantly in cranial blood vessels and mediates vasoconstriction. |
List of Excipients |
---|
Sodium chloride |
Treatment pack: 2 pre-filled syringes (in cases) plus an auto-injector, in a plastic tray within a carton.
Refill pack: 2 pre-filled syringes (in cases) in a carton or 6 pre-filled syringes (ie three cases each containing 2 pre-filled syringes).
Glaxo Wellcome UK Limited
Trading as GlaxoSmithKline UK, 980 Great West Road, Brentford, Middlesex, TW8 9GS
PL 10949/0113
Date of first authorisation: 31 December 1993
Date of latest renewal: 11 July 2007
Drug | Countries | |
---|---|---|
IMIGRAN | Austria, Australia, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.